Orthopedic Industry Outlook Prompts Positive Market Sentiment
Amid a deteriorating macroeconomic backdrop, orthopedic industry stocks have shown resiliency relative to the broader public markets. This enables management teams to breathe a sigh of relief, driven in part by expectations for a long-awaited pickup in procedure volumes, as they and investors have watched valuations tumble over recent years due to COVID-19 headwinds, supply-chain backlogs, and other industry forces.
Orthopedic Industry Outlook Prompts Positive Market Sentiment
Published in MedTech Strategist
Authors: Oded Ben-Joseph, PhD, Thomas F. Busby, and
Derrick Holmes, CFA
Abstract:
Amid a deteriorating macroeconomic backdrop, orthopedic industry stocks have shown resiliency relative to the broader public markets. This enables management teams to breathe a sigh of relief, driven in part by expectations for a long-awaited pickup in procedure volumes, as they and investors have watched valuations tumble over recent years due to COVID-19 headwinds, supply-chain backlogs, and other industry forces.
News
Outcome Capital Expands Life Science and Healthcare Advisory Capabilities with Addition of Dr. David Feygin to Medical Device, Digital Health and AI Practices
BOSTON–(BUSINESS WIRE)–Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced the addition of Dr. David Feygin as a Senior Advisor to the firm’s Medical Device, Digital Health and AI practices. The appointment expands Outcome Capital’s strategic advisory capabilities in the rapidly evolving intersection of life sciences, healthcare, […]
Read MoreResources
Outcome Capital Life Science Market Pulse
Outcome Capital Life Science Market Pulse April 2026 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
